Ines Horvat-Menih
Articles
-
Sep 12, 2024 |
medrxiv.org | Pascal Wodtke |Mary A McLean |Ines Horvat-Menih |Jonathan Birchall
The authors have declared no competing interest. ISRCTN: 13008110PW acknowledges support from the Gates Cambridge Trust (#OPP1144). MM acknowledges support from the Cambridge Experimental Cancer Medicine Centre. This research was further supported by Cancer Research UK (CRUK; C19212/A27150; C19212/A29082), CRUK Cambridge Centre, Wellcome Trust, NIHR Cambridge Biomedical Research Centre (BRC-1215-20014).
-
Sep 12, 2024 |
The authors have declared no competing interest. ISRCTN: 13008110PW acknowledges support from the Gates Cambridge Trust (#OPP1144). MM acknowledges support from the Cambridge Experimental Cancer Medicine Centre. This research was further supported by Cancer Research UK (CRUK; C19212/A27150; C19212/A29082), CRUK Cambridge Centre, Wellcome Trust, NIHR Cambridge Biomedical Research Centre (BRC-1215-20014).
-
Jun 20, 2024 |
medrxiv.org | Ines Horvat-Menih |Jonathan Birchall |Maria J Zamora-Morales |Alice Bebb
GDS has received educational grants from Pfizer, AstraZeneca and Intuitive Surgical; consultancy fees from Pfizer, MSD, EUSA Pharma and CMR Surgical; Travel expenses from MSD and Pfizer; Speaker fees from Pfizer; Clinical lead (urology) National Kidney Cancer Audit and Topic Advisor for the NICE kidney cancer guideline. S.J.W. is a founder and director of Pinto Medical Consultancy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →